Bank of New York Mellon’s LeMaitre Vascular LMAT Stock Holding History

Bank of New York Mellon’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.5M	Buy	172,458 +5,130	+3%	+$526K	﹤0.01%	1745
2026 Q1	$18.3M	Sell	167,328 -3,465	-2%	-$330K	﹤0.01%	1591
2025 Q4	$13.9M	Buy	170,793 +4,515	+3%	+$389K	﹤0.01%	1733
2025 Q3	$14.6M	Sell	166,278 -4,196	-2%	-$375K	﹤0.01%	1719
2025 Q2	$14.2M	Sell	170,474 -7	-0%	-$585	﹤0.01%	1703
2025 Q1	$14.3M	Sell	170,481 -8,266	-5%	-$769K	﹤0.01%	1669
2024 Q4	$16.5M	Sell	178,747 -6,048	-3%	-$582K	﹤0.01%	1681
2024 Q3	$17.2M	Sell	184,795 -25,804	-12%	-$2.24M	﹤0.01%	1668
2024 Q2	$17.3M	Buy	210,599 +5,213	+3%	+$383K	﹤0.01%	1662
2024 Q1	$13.6M	Sell	205,386 -10,849	-5%	-$669K	﹤0.01%	1798
2023 Q4	$12.3M	Sell	216,235 -23,091	-10%	-$1.21M	﹤0.01%	1864
2023 Q3	$13M	Sell	239,326 -4,855	-2%	-$288K	﹤0.01%	1788
2023 Q2	$16.4M	Buy	244,181 +1,699	+0.7%	+$104K	﹤0.01%	1661
2023 Q1	$12.5M	Sell	242,482 -8,602	-3%	-$418K	﹤0.01%	1815
2022 Q4	$11.6M	Buy	251,084 +4,556	+2%	+$213K	﹤0.01%	1867
2022 Q3	$12.5M	Buy	246,528 +3,800	+2%	+$190K	﹤0.01%	1762
2022 Q2	$11.1M	Buy	242,728 +8,353	+4%	+$374K	﹤0.01%	1874
2022 Q1	$10.9M	Sell	234,375 -945	-0.4%	-$42.3K	﹤0.01%	2026
2021 Q4	$11.8M	Sell	235,320 -3,201	-1%	-$165K	﹤0.01%	2013
2021 Q3	$12.7M	Buy	238,521 +18,670	+8%	+$1.05M	﹤0.01%	1994
2021 Q2	$13.4M	Sell	219,851 -15,707	-7%	-$834K	﹤0.01%	1972
2021 Q1	$11.5M	Buy	235,558 +1,935	+0.8%	+$90.7K	﹤0.01%	2014
2020 Q4	$9.46M	Sell	233,623 -1,933	-0.8%	-$69.1K	﹤0.01%	2035
2020 Q3	$7.66M	Sell	235,556 -1,725	-0.7%	-$51.8K	﹤0.01%	1988
2020 Q2	$6.26M	Buy	237,281 +5,369	+2%	+$140K	﹤0.01%	2100
2020 Q1	$5.78M	Sell	231,912 -15,348	-6%	-$474K	﹤0.01%	2009
2019 Q4	$8.89M	Sell	247,260 -9,540	-4%	-$329K	﹤0.01%	2047
2019 Q3	$8.78M	Sell	256,800 -6,051	-2%	-$193K	﹤0.01%	2000
2019 Q2	$7.36M	Buy	262,851 +8,942	+4%	+$248K	﹤0.01%	2137
2019 Q1	$7.87M	Sell	253,909 -3,081	-1%	-$82.2K	﹤0.01%	2093
2018 Q4	$6.08M	Buy	256,990 +3,841	+2%	+$105K	﹤0.01%	2181
2018 Q3	$9.81M	Buy	253,149 +6,705	+3%	+$242K	﹤0.01%	2036
2018 Q2	$8.25M	Buy	246,444 +7,177	+3%	+$255K	﹤0.01%	2125
2018 Q1	$8.67M	Buy	239,267 +6,451	+3%	+$223K	﹤0.01%	2051
2017 Q4	$7.41M	Buy	232,816 +14,698	+7%	+$503K	﹤0.01%	2148
2017 Q3	$8.16M	Buy	218,118 +7,490	+4%	+$255K	﹤0.01%	2086
2017 Q2	$6.57M	Buy	210,628 +122,076	+138%	+$3.53M	﹤0.01%	2188
2017 Q1	$2.18M	Buy	88,552 +1,408	+2%	+$33.1K	﹤0.01%	2801
2016 Q4	$2.21M	Buy	87,144 +3,393	+4%	+$75.3K	﹤0.01%	2788
2016 Q3	$1.66M	Buy	83,751 +2,738	+3%	+$47.8K	﹤0.01%	2874
2016 Q2	$1.16M	Buy	81,013 +20,803	+35%	+$318K	﹤0.01%	3042
2016 Q1	$934K	Buy	60,210 +15	+0%	+$215	﹤0.01%	3104
2015 Q4	$1.04M	Buy	60,195 +23,521	+64%	+$340K	﹤0.01%	3145
2015 Q3	$447K	Sell	36,674 -11,276	-24%	-$145K	﹤0.01%	3624
2015 Q2	$579K	Buy	47,950 +33,829	+240%	+$333K	﹤0.01%	3586
2015 Q1	$118K	Buy	14,121 +14	+0.1%	+$110	﹤0.01%	4006
2014 Q4	$108K	Sell	14,107 -23,372	-62%	-$167K	﹤0.01%	4020
2014 Q3	$258K	Sell	37,479 -719	-2%	-$5.37K	﹤0.01%	3823
2014 Q2	$316K	Buy	38,198 +147	+0.4%	+$1.15K	﹤0.01%	3731
2014 Q1	$307K	Buy	38,051 +309	+0.8%	+$2.47K	﹤0.01%	3736
2013 Q4	$302K	Buy	37,742 +23,635	+168%	+$183K	﹤0.01%	3746
2013 Q3	$95K	Hold	14,107	–	–	﹤0.01%	3966
2013 Q2	$92K	Buy	+14,107	New	+$88.9K	﹤0.01%	3946

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of New York Mellon's LMAT Position: Q2 2026 in Review

Bank of New York Mellon increased its LeMaitre Vascular (LMAT) stake by 3.1% in Q2 2026, buying an estimated $526K and bringing the position to 172,458 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Bank of New York Mellon first reported a position in LMAT in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.3M in Q1 2026. 160 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Bank of New York Mellon held 172,458 shares of LeMaitre Vascular worth $16.5M as of Q2 2026.
Bank of New York Mellon bought 5,130 LeMaitre Vascular shares in Q2 2026, an estimated $526K.
LeMaitre Vascular made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1745 holding.
Bank of New York Mellon first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's LeMaitre Vascular position peaked at $18.3M in Q1 2026.
160 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.